SVR in HIV-HCV coinfected patients can be enhanced by optimizing dosing of pegylated interferon and ribavirin therapy

被引：0
|
作者：
Monto, Alexander
Rodriguez, Rebecca F.
Currie, Sue
George, Sally
Lee, Natalie
Tracy, Daniel P.
Wright, Teresa L.
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A794 / A794
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of interferon and ribavirin therapy in HIV-HCV coinfected patients
    Zylberberg, H
    Benhamou, Y
    Chaix, ML
    Fontaine, H
    Rouzioux, C
    Katlama, C
    Poynard, T
    Bréchot, C
    Pol, S
    [J]. JOURNAL OF HEPATOLOGY, 2000, 32 : 178 - 178
  • [2] Chorea during treatment with pegylated interferon and ribavirin in HIV-HCV coinfected patient
    Luisa Montes, Maria
    Maria Fraile, Jose
    Julian Gonzalez, Juan
    Ramon Arribas, Jose
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2009, 27 (01): : 60 - 61
  • [3] Hcv dynamics in HIV/HCV coinfected patients treated with pegylated interferon and ribavirin.
    Talal, AH
    Shata, MT
    Flynn, SM
    Dorante, G
    Laughlin, M
    Ribeiro, RM
    Perelson, AS
    [J]. HEPATOLOGY, 2002, 36 (04) : 205A - 205A
  • [4] Aggressive daily interferon therapy in HIV-HCV coinfected patients
    Bruno, R
    Sacchi, P
    Filice, C
    Filice, G
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (04) : 372 - 373
  • [5] Predictive value of early virological response (12 weeks) to pegylated interferon plus ribavirin in HIV-HCV coinfected patients
    Perez-Olmeda, M
    Martin-Carbonero, L
    Romero, M
    Rios, P
    Nunez, M
    Soriano, V
    Garcia-Samaniego, J
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 163 - 163
  • [6] Extended Therapy With Pegylated Interferon and Weight-Based Ribavirin for HCV-HIV Coinfected Patients
    Chung, Raymond T.
    Umbleja, Triin
    Chen, Jennifer Y.
    Andersen, Janet W.
    Butt, Adeel A.
    Sherman, Kenneth E.
    [J]. HIV CLINICAL TRIALS, 2012, 13 (02): : 70 - 82
  • [7] ANTIRETROVIRALS REDUCE RIBAVIRIN EXPOSURE IN HIV-HCV COINFECTED PATIENTS
    Quioc, Jean-Jacques
    Jullien, Vincent
    Mallet, Vincent
    Nalpas, Bertrand
    Pol, Stanislas
    [J]. HEPATOLOGY, 2008, 48 (04) : 874A - 874A
  • [8] Daily interferon therapy in HIV-HCV coinfected patients: Preliminary report.
    Bruno, R
    Sacchi, P
    Debiaggi, M
    Filice, C
    Brunetti, E
    Patruno, SFA
    Valentina, C
    Zocchetti, C
    Zara, F
    Filice, G
    [J]. HEPATOLOGY, 2000, 32 (04) : 349A - 349A
  • [9] Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients
    Fumaz, C. R.
    Munoz-Moreno, J. A.
    Ballesteros, A. L.
    Paredes, R.
    Ferrer, M. J.
    Salas, A.
    Fuster, D.
    Masmitja, E.
    Perez-Alvarez, N.
    Gomez, G.
    Tural, C.
    Clotet, B.
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2007, 19 (01): : 138 - 145
  • [10] Efficacy and tolerability after 24 weeks of treatment with telaprevir, pegylated interferon and ribavirin in cirrhotic HIV-HCV coinfected subjects
    Genebat, Miguel
    Vera, Francisco
    Hernandez-Quero, Jose
    Domingo, Pere
    Guardiola, Jose M.
    Martinez-Madrid, Onofre
    Martinez, Lorena
    Garcia de la Liana, Francisco
    Sanchez-Villegas, Jorge
    Alvarez, Hortensia
    Marino, Ana
    Lluch, Jose F.
    Martinez-Perez, Maria A.
    Marin, Jorge
    Ruiz-Mateos, Ezequiel
    Leal, Manuel
    [J]. ANTIVIRAL RESEARCH, 2014, 104 : 59 - 61
12345